India, Nov. 19 -- Marksans Pharma Limited announced that its wholly owned subsidiary, Marksans Pharma Inc., has received final USFDA approval for its ANDA for Loperamide Hydrochloride Tablets USP, 2 mg (OTC).
The approved product is bioequivalent to Imodium A-D Tablets, 2 mg, the reference listed drug (RLD) of Kenvue Brands LLC (NDA 019860).
Loperamide Hydrochloride is an anti-diarrheal medication indicated for the management of acute and chronic diarrhea.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....